Moneycontrol
Get App
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 20, 16:00
321.35 3.45 (1.09%)
Volume
AVERAGE VOLUME
5-Day
149,233
10-Day
102,377
30-Day
79,444
60,031
  • Prev. Close

    317.90

  • Open Price

    319.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 20, 15:57
321.55 3.45 (1.08%)
Volume
AVERAGE VOLUME
5-Day
3,254,420
10-Day
2,254,446
30-Day
1,994,637
1,529,171
  • Prev. Close

    318.10

  • Open Price

    318.10

  • Bid Price (Qty.)

    321.55 (664)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Half Yearly Results of Glenmark Pharma (in Rs. Cr.) Sep '19 Mar '19 Sep '18 Mar '18 Sep '17  
Net Sales/Income from operations 3,197.86 3,130.66 3,000.48 2,965.57 3,130.48  
Other Operating Income 90.76 88.66 85.07 258.72 77.11  
Total Income From Operations 3,288.61 3,219.32 3,085.55 3,224.29 3,207.59  
EXPENDITURE  
Consumption of Raw Materials 1,086.96 791.44 794.42 1,053.72 984.84  
Purchase of Traded Goods 189.49 138.51 162.79 152.46 135.71  
Increase/Decrease in Stocks 10.40 314.40 157.41 4.28 47.56  
Power & Fuel -- -- -- -- --  
Employees Cost 565.81 456.31 513.67 487.73 534.19  
Depreciation 65.49 52.05 54.23 59.37 58.83  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 746.78 900.55 747.90 928.99 754.88  
P/L Before Other 623.69 566.05 655.15 537.74 691.56  
Other Income 261.01 83.75 391.87 81.53 98.89  
P/L Before Int. 884.69 649.80 1,047.01 619.27 790.46  
Interest 133.24 107.79 116.02 97.72 93.18  
P/L Before Exceptional Items & Tax 751.45 542.01 930.99 521.55 697.28  
Exceptional Items -- -- 345.19 -- --  
P/L Before Tax 751.45 542.01 1,276.17 521.55 697.28  
Tax 91.62 91.30 238.58 105.92 98.56  
P/L After Tax from Ordinary Activities 659.84 450.71 1,037.59 415.63 598.72  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- 26.45 107.36 -- --  
Net Profit/(Loss) For the Period 659.84 477.16 1,144.95 415.63 598.72  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 23.38 -- 40.58 -- 21.22  
Diluted EPS 23.38 -- 40.58 -- 21.21  
EPS After Extra Ordinary  
Basic EPS. 23.38 -- 40.58 -- 21.22  
Diluted EPS. 23.38 -- 40.58 -- 21.21  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited